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Abstract
Background: Delineating the molecular drivers of cancer, i.e. determining cancer genes and the pathways which
they deregulate, is an important challenge in cancer research. In this study, we aim to identify pathways of frequently
mutated genes by exploiting their network neighborhood encoded in the protein-protein interaction network. To this
end, we introduce a multi-scale diﬀusion kernel and apply it to a large collection of murine retroviral insertional
mutagenesis data. The diﬀusion strength plays the role of scale parameter, determining the size of the network
neighborhood that is taken into account. As a result, in addition to detecting genes with frequent mutations in their
genomic vicinity, we ﬁnd genes that harbor frequent mutations in their interaction network context.
Results: We identify densely connected components of known and putatively novel cancer genes and demonstrate
that they are strongly enriched for cancer related pathways across the diﬀusion scales. Moreover, the mutations in the
clusters exhibit a signiﬁcant pattern of mutual exclusion, supporting the conjecture that such genes are functionally
linked. Using multi-scale diﬀusion kernel, various infrequently mutated genes are found to harbor signiﬁcant numbers
of mutations in their interaction network neighborhood. Many of them are well-known cancer genes.
Conclusions: The results demonstrate the importance of deﬁning recurrent mutations while taking into account the
interaction network context. Importantly, the putative cancer genes and networks detected in this study are found to
be signiﬁcant at diﬀerent diﬀusion scales, conﬁrming the necessity of a multi-scale analysis.
Background
Cancer is a complex genetic disease, caused by a multistep
process in which several collaborating mutations allow a
cell to evade the checkpoints that normally safeguard it
against DNA damage and other disruptions of healthy cell
growth [1-3]. Among all human genes more than 1% are
implicated in cancer by somatic or germline mutations
[4]. This implies that hundreds of genes may contribute to
tumor formation. This percentage is expected to increase
since cancer genome sequencing of human tumors [5] and
forward genetics screens in model organisms [6-8] are
providing evidence for thousands more [9]. Arguably, can-
cer genes are thus better considered as contributing to
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cancer rather than causal for cancer [10], as their eﬀect is
dependent on many other genetic aberrations.
One of the major challenges in cancer research is to
determine all genes that contribute to the disease as well
as delineate the pathways through which these genes exert
their malicious eﬀects on a cellular process. A potent way
of discovering genes driving carcinogenesis is to perform
forward genetic screens in animal models such as retrovi-
ral or transposon insertional mutagenesis (IM). Retroviral
insertional mutagenesis (RIM) is based on integration of
a retrovirus into the host cell’s genome, mutating the host
cell’s DNA in the process. Putative cancer genes in the
RIM datasets are determined by searching for genes in the
vicinity of genomic regions that harbor recurrent muta-
tions across multiple independent tumors [6,7,11]. Such
regions in the genome are called Common Insertion Sites
(CIS). Statistical signiﬁcance of CIS can be determined by
means of permutation strategies [12].
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A major problem in this approach is that, assuming
realistic sample sizes, not all cancer-associated genes har-
bor suﬃcient mutations in multiple tumors to be called
signiﬁcant. This is because mutations in the vicinity of dif-
ferent genes can exert the same deleterious eﬀect on the
same pathway [10]. This explains that mutations of diﬀer-
ent genes represent alternative routes to the acquisition
of the same cancer hallmark [13,14]. A compelling exam-
ple is given by the Rb pathway. Mutations in four genes
RB1, CDKN2A, CDK4, and CCND1 can be considered
equivalent because their eﬀect on controlling transition
to replication phase is similar [10]. On the other hand,
acquisitions of some cancer hallmarks require mutations
of multiple genes. Examples of this include the frequently
observed co-mutation of RAS and TP53 [15]. Co-mutated
genes can thus be considered to collaborate in carcinogen-
esis [16].
An important implication of this fact is that the def-
inition of a recurrent gene mutation, deﬁned as a gene
that harbors frequent mutations in its genomic vicinity in
more tumors than expected by chance, is no longer appro-
priate. Instead, recurrent mutations should be deﬁned at
the scale of a pathway, rather than the scale of a single
gene.
A straightforward approach would be to regard muta-
tions aﬀecting diﬀerent genes in the same pathway as
recurrent by a summarization across pathways deﬁned in
databases such as KEGG [17] and using enrichment statis-
tics such as GSEA [18]. Here, we argue against such an
approach for the following reasons. First, such approaches
consider a pathway as a group of genes, and thus, disre-
gard any topological information in the gene interaction
network that describes a pathway. Edge weights, captur-
ing conﬁdence in a certain relation, are also not taken into
account. Most importantly, however, gene sets that are
deﬁned based on a pathway represent only one of many
scales at which this pathway can be deﬁned. In reality,
mutations may target very speciﬁc components of a path-
way (i.e. small-scale), whereas in other cases summariza-
tion across a collection of functionally similar pathways
(i.e. large-scale) may be justiﬁed.
When a pathway is deﬁned at a scale which is too small,
mutations are split across diﬀerent distinct pathways. As
a result, mutations are only recurrent across a relatively
small number of tumors. This implies loss of power to
detect relevant mutation patterns. On the other hand,
when a pathway is deﬁned at a scale which is too large,
many irrelevant genes are considered that do not har-
bor mutation. This also implies reduced power to detect
recurrence. Since it is a priori unknown at which scale it
is most appropriate to summarize mutations and deﬁne
a pattern of recurrent mutation, a multi-scale approach
that evaluates pathway descriptions of diﬀerent scales
is required.
For this reason, we propose to consider gene mutations
in the context of its pathway neighborhood as encoded
in a functional protein-protein interaction (PPI) network
[19]. This network describes a variety of gene and pro-
tein interactions (including experimentally veriﬁed phys-
ical interactions, co-expressed genes, interactions mined
from literature, known pathway interactions, interactions
predicted from protein homology, etc.). Importantly, this
oﬀers the possibility to obtain a more continuous def-
inition of the size of the pathway neighborhood, or, in
other words, a less discrete deﬁnition of the scale at which
the interaction network context is considered. Using a
multi-scale diﬀusion kernel [20] (detailed in the Methods
section), this scale can be varied across a range of values.
This enables analysis of the mutations in interaction con-
texts of diﬀerent scale, ranging from small-scale signaling
cascades to large-scale molecular pathways.
The PPI network has been successfully used to deﬁne
subnetworks with predictive value for patient prognosis
from gene expression data [21-26]. Other approaches use
PPI information to identify subnetworks with frequent
mutations, since these may point to commonly mutated
pathways [27,28]. In both cases, a scoring function is
optimized to identify high-scoring subnetworks. How-
ever, these types of optimizations are NP-hard and there-
fore require heuristic strategies that are computationally
expensive [25-27].
Here, we propose a diﬀerent approach, based on dif-
fusion kernel, to determine genes recurrently mutated
in interaction context (ReMIC genes). ReMIC genes are
detected when the gene itself or the interaction network
neighborhood of the gene harbors more mutations than
expected by chance (Figure 1). The amount of diﬀu-
sion determines the scale of the network neighborhood
that will be taken into account. A permutation analysis
is employed to determine the signiﬁcance of a ReMIC
gene within the context of its network neighborhood at
a particular scale. By varying this scale across a range of
values, ReMIC genes that arise as a result of mutations in
small, well-connected subnetworks (small-scale) as well as
those that arise as a result of mutations in large pathway
components (large-scale) can be identiﬁed.
The proposed approach establishes signiﬁcance esti-
mates per gene, mitigating the need of excessive correction
for multiple testing that arises when testing many net-
works of diﬀerent sizes. It also requires no prior assump-
tions on the size of subnetworks. However, the major
beneﬁt is that our method explicitly takes care of the scale
at which a subnetwork is considered.
In the following, we outline the proposed methodology
and show results on a large collection of viral mutation
data from two large RIM screens [6,11]. In particular,
we show that diﬀerent networks of recurrent mutations
arise at diﬀerent scales. Many genes that do not harbor















Figure 1 Framework. A) Insertion mutation data (blue lollipops, each occurring in one tumor) across a set of tumors (not shown) and four
genomic regions. The region on Chr 5 and Chr 7 harbor suﬃcient mutations to be called CIS. The region on Chr 11 and Chr 16 do not. B) Gene
mutation scores are obtained by weighted summarization. The weighing function is a ﬂat-top Gaussian. C) PPI network with genes as nodes. Color
denotes the mutation gene score. D) Illustration of the diﬀusion kernel. Conceptually, the diﬀusion kernel is similar to a heat diﬀusion process. In
graphs this means that the mutation score at the graph node is diﬀused throughout the network dependent on the graph topology that connects
this node to the rest of the network. Its global distance to the other nodes is thus dependent on the weight and number of paths connecting them
as well as the diﬀusion strength. The latter parameter can be regarded as a scale parameter. For low diﬀusion strength, scores hardly diﬀuse and the
interaction context of a gene is determined by itself and a few well-connected neighbors. For high diﬀusion strength, scores are almost fully
diﬀused and can thus reach distant genes in the network, albeit in very small amounts. Using a permutation approach, it is possible to establish
whether the diﬀused scores are higher than expected by chance (starred genes). Notably, genes with few or no mutations can still reach
signiﬁcance due to high scoring nodes in their neighborhood.
suﬃcient mutations to be called signiﬁcant in a genome-
based analysis are identiﬁed using the proposed approach.
A signiﬁcant portion of these genes are well-known can-
cer genes. In addition, we determine densely connected
subnetworks of the signiﬁcant genes which are highly
enriched for cancer related pathways at diﬀerent diﬀusion
strength. These clusters also show signiﬁcant patterns of




Retroviral insertional mutation data is acquired from
Mutapedia (available on http://mutapedia.nki.nl). In total,
the dataset contains 19 997 viral insertions in 933 tumors
that have been produced in mice with various genetic
backgrounds [11]. All insertions in this dataset are
mapped to Ensembl genes by employing a ﬂat-top Gaus-
sian scoring function (Figure 1B). This scoring function is
uniform within a gene and has Gaussian tails outside the
gene. The width (standard deviation) of the Gaussian is
chosen to be 25kb, based on observations made in de Jong
et al. [29]. Insertions further than 50kb from the gene start
or gene termination site are not associated to that gene. In
this way, we obtain a (t × g) mutation matrix M where t
is the number of tumors in the study, g is the number of
genes in the PPI network and Mij indicates the mutation
score of gene j in tumor i. The mutation score vector S
capturs the insertion frequency in the vicinity of each gene
and is computed as: Sj =∑∀i Mij (Figure 1).
Interaction graph construction
A PPI graph is obtained from STRING [19]. The com-
bined scores are used as interaction weights between
proteins. To associate proteins in the PPI network to their
corresponding genes, Ensembl gene IDs are mapped to
protein IDs. In case of multiple proteins mapping to the
same gene, interaction weights are collapsed into a single
gene-to-gene interaction weight by averaging. We retain
reliable interactions by removing all links with a weight
below threshold TI . As a result, we obtain an undirected
and weighted interaction networkN = (G, I, S,W ), where
G denotes a set of nodes representing the genes, I denotes
a set of edges representing interaction edges between pro-
teins associated with the Ensembl genes, vector S denotes
mutation scores per gene, and weight matrix W denotes
the interaction weights between the genes.
Diﬀusion kernel
To represent the interaction network context of a gene, it
is desirable to obtain a global similarity metric that cap-
tures the local topology of the network connecting two
genes. To this end, we use the diﬀusion kernel approach
proposed by Kondor and Laﬀerty [20].
Babaei et al. BMC Bioinformatics 2013, 14:29 Page 4 of 12
http://www.biomedcentral.com/1471-2105/14/29
The diﬀusion kernel of a weighted interaction graph N
is described by:
Kβ = eβL
where eβL denotes the matrix exponential and the β >= 0
is the diﬀusion parameter that controls the extent of diﬀu-
sion (i.e. the scale). Matrix L is equivalent to the Laplacian




− Wij if i = j∑n
l=1Wil if i = j
The Laplacian matrix L thus represents the graph topol-
ogy of graph N, while the diﬀusion kernel Kβ provides a
smooth global similarity measure on N.
The diﬀusion parameter β plays an important role as it
controls the extent of the diﬀusion. For β equal to 0, there
is no diﬀusion (i.e. K0 = I) while for β approaching inﬁn-
ity the diﬀusion reaches equilibriumwhere all (connected)
nodes receive the same diﬀusion contribution. Diﬀusion
Diﬀusion kernel matrices are created for a range of β val-
ues. Finally, each diﬀusion kernel matrix is applied to the
gene mutation score vector, to obtain diﬀused mutation
scores, by calculating SKβ .
Permutation procedure
Signiﬁcance estimates, establishing whether a gene’s dif-
fusion score is higher than expected by chance, are
calculated on a per gene and per scale basis by permuta-
tion analysis. To this end, we randomize the association
between genes and mutations by permuting the mutation
scores in each tumor independently and recalculating the
overall mutation score vector S. The diﬀusion kernel at
a particular scale is then applied to the randomized S.
This procedure is repeated 107 times, resulting in a null-
distribution per gene from which an empirical p-value
(including pseudocount) can be calculated.
To reduce the computational burden, we precompute
105 random score vectors S and store these in vector
Srnd. In every permutation iteration, g scores are randomly
selected from Srnd. Moreover, the permutation procedure
for a gene is discontinued when more than 10 permuted
diﬀused scores exceed its non-permuted diﬀused score.
As a result, the permutation procedure is procedure is
carried out for fewer genes, reducing the computational
burden considerably. Correction for multiple testing is
achieved by using the method of Storey and Tibshirani to
calculate a false discovery rate (FDR) per gene [30]. The p-
values are adjusted by considering the number of genes in
the PPI network as well as the number of scales at which
the diﬀusion kernel is employed. Genes exceeding the α-
level are called ReMIC genes. The source code is available
in Additional ﬁle 1.
Graph clustering
In this study, we divide subnetworks of signiﬁcant genes
into densely connected subgroups by applying the Girvan-
Newman graph clustering method that uses a natural
division of the graph into clusters based on the strength
of connections between the nodes [31]. In this algorithm,
a betweenness score of an edge is computed based on the
number of shortest paths that ﬂow through that edge. A
high betweenness score means that this particular edge
connects clusters with densely connected nodes. A den-
drogram is constructed by gradually removing the edges
with the highest betweenness score. The root of the den-
drogram represents the original network and the leaves
are individual genes (Additional ﬁle 2: Figure S6-S11). For
each division of the network into clusters a modularity
measure is calculated which indicates the fraction of edges
in the network that connect nodes in the same clusters.
The dendrogram is cut at the point where the maximum
modularity is achieved.
To calculate a modularity measure for a particular divi-
sion of the network with n clusters a symmetric (n × n)
matrix E is deﬁned. The matrix entry Eij is the fraction
of all edges in the network that connect nodes in clus-
ter i to nodes in cluster j. The trace of E (TE) indicates
the fraction of edges in the network that link nodes in the
same cluster. Accordingly, a high value ofTE demonstrates
a good division of the network into densely connected
clusters. However, TE itself yields no information about
the structure of clusters, since, for example, a single clus-
ter consisting of all nodes results in a maximal value of
TE while it is not a good division of the network. For
this reason the trace of E − ‖E2‖ is used as a modular-
ity measure where ‖E2‖ indicates the sum of the entries
of the matrix E2. This modularity measure is the fraction
of the edges in the network that link nodes in the same
cluster minus the expected value of the same quantity for
randomized network (in which edges are distributed at
random without considering the structure of clusters). A
modularity measure equal to zero means that the num-
ber of within-cluster edges is not better than random
connections. A good division of densely connected clus-
ters results in a modularity measure close to one. The
modularity measure is calculated for each division of
the network and the best cut-level of the dendrogram is
determined based on the maximum modularity. In this
work, we use Cytoscape plugin [32] GLay community
structure analysis that implements the Girvan-Newman
algorithm [33].
KEGG pathway enrichment
In order to get a general idea of the function of ReMIC
gene clusters, KOBAS [34] is applied to calculate KEGG
pathway enrichments. More speciﬁcally, we use KOBAS
to determine overlap of a ReMIC gene cluster with all
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known pathways in the KEGG database [17]. For each
pathway that occurs in the input gene set, KOBAS counts
the total number of input genes that are involved in the
pathway. It also counts the total number of genes in the
background gene set (all genes in the interaction network)
that are involved in the same pathway. A p-value of the
pathway enrichment is calculated using the Fisher exact
test with Benjamini FDR correction to adjust for multiple
testing.
Mutual exclusivity analysis
To determine whether the genes in a subnetwork exhibit
more than random mutual exclusion of mutations (i.e.
mutations in diﬀerent genes of the subnetwork tend not to
co-occur within the same tumor), we employ the mutual
exclusivity module (MEMo) approach [35]. The mutation
matrixM is considered as the adjacency matrix of a graph
where Mgt > 0, represents an edge connecting gene g to
tumor t. The switching permutation technique is applied
to generate 104 random mutation matrices [36].
In the switching permutation method, a randomized
mutation matrix is generated from the original mutation
matrixMwhile the overall adjacency distribution between
genes and tumors is preserved. To do this, two edges are
randomly selected between gene g1 and tumor t1 (g1, t1)
and gene g2 and tumor t2 (g2, t2). If these edges appear in
the adjacency graph of M (i.e. Mg1t1 and Mg2t2 are non-
zero entries) the ends of the are non-zero entries) the ends
of the edges are swapped to give (g1, t2) and (g2, t1). This
exchange is only allowed if it generates no duplicate edges
between a gene and a tumor. The process is repeated for
k×q iterations where k is the total number of edges in the
adjacency graph of M and q is a constant number. It has
been empirically shown that q = 100 is adequate for many
networks [36].
The resulting random mutation matrices are then used
to calculate an empirical p-value for a gene cluster. The p-
values are calculated as the fraction of permutations that
lead to a greater or equal number of mutations than those
observed in M. Genes within signiﬁcant clusters (with α-
level of 0.05) are considered to be more mutually exclusive
than expected by chance.
Results and discussion
Identifying Genes Recurrently Mutated in Interaction
Context (ReMIC)
We apply our method to the obtained interaction graph
(N) as described in the Methods section. This graph con-
tains reliable interaction links with scores more than the
median value of the combined scores of all interactions
(TI = 500). This is a trade-oﬀ between high-conﬁdence
interactions (score > 700) and low-conﬁdence interac-
tions (score< 400) [19]. The resulting interaction graphN
with edge weights W , contains 14 842 nodes and 448 472
edges. The mutation scores S are computed as described
in the Methods section for all genes present in the inter-
action network.
The diﬀusion kernel is applied to the complete PPI
graph N for a range of scales by varying β in the range
[ 0, 0.03]. A permutation procedure is performed to obtain
p-values for each gene and each scale separately. Genes
recurrently mutated in their interaction context (ReMIC
genes) are deﬁned as nodes that are signiﬁcant at an
α-level of 0.001 (Additional ﬁle 3). ReMIC genes are pre-
sented within the context of their original protein-protein
interactions. The resulting ReMIC network is clustered
using Girvan-Newman clustering technique (Additional
ﬁle 2: Figure S6-S11). The resulting clusters are called
ReMIC gene clusters.
ReMIC genes are organized in connected components
Inspection of the signiﬁcant genes at the various diﬀusion
scales reveals that the vast majority of them are orga-
nized in connected components. This demonstrates that,
even though the signiﬁcance estimates are performed on
a per gene bases, the diﬀusion process captures groups of
signiﬁcant genes that are connected in the PPI network.
For β equal to 0 there is no diﬀusion. Hence, all signif-
icant genes at this scale harbor suﬃcient mutations to be
called signiﬁcant irrespective of their protein interaction
context. Indeed, the collection of signiﬁcant genes at this
scale represents the known CIS network, since virtually
all of these genes have been previously discovered in the
analysis of the original screen using traditional CIS anal-
ysis [11]. A substantial fraction of them are known tumor
suppressors or oncogenes such as Gﬁ1, Notch1 and Myc
[37]. Figure 2A shows these CISs and the protein-protein
interactions between them.
When the scale is increased, genes gradually diﬀuse
their scores across the network. High scoring nodes that
are connected to many low scoring nodes diﬀuse their
score rapidly, whereas low scoring nodes with few con-
nections diﬀuse their score more slowly. As a result, genes
with relatively low (pink) or zero (white) mutation score
are more included at higher scales as demonstrated in
Figure 2B for three speciﬁc diﬀusion scale levels (β) repre-
senting small-, medium- and large-scale. Therefore, while
CIS genes have high initial scores, the ReMIC genes arise
as a result of mutations in their network neighborhood
rather than in their genomic vicinity alone. It should be
noted that the CIS genes do contribute to the signiﬁcance
of ReMIC genes by virtue of score diﬀusion through the
local graph topology.
ReMIC gene clusters strongly enriched for cancer related
pathways
A striking observation from the ReMIC gene clusters
across the scales is that, in addition to some small clus-





























Figure 2 Gene clusters across the diﬀusion scales. A) The CIS genes shown in the context of the interaction network which are signiﬁcant
without any diﬀusion (β = 0). These genes represent the major sources of mutation score, and drive low scoring genes in the diﬀusion process. B)
Overview of the identiﬁed ReMIC gene clusters at three scale levels: small-, medium- and large-scale. The color of the nodes reﬂects the mutation
score before diﬀusion. Two major gene clusters, Runx- and Pik3-cluster are apparent across the scales. C) p-values of pathway enrichment analysis of
three pathways in the KEGG database for two detected clusters in all diﬀusion scales. Both clusters are highly enriched for pathways in cancer across
a range of scales. The Runx- and Pik3-cluster show strongest enrichment for the small- and large-scale, respectively. D) p-values of mutual exclusivity
analysis for the two ReMIC gene clusters. Both clusters are signiﬁcantly mutually exclusive across all scale levels. The minimum p-value is, however,
attained for the scale at which the strongest KEGG enrichment was observed.
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ters, two major gene clusters are apparent (indicated in
Figure 2B). It is apparent that these clusters gradually
increase size as the scale parameter increases. In the
following, we refer to these clusters as the Runx- and
Pik3-cluster.
To examine if one scale is more relevant than other
scales, we investigate KEGG pathway enrichments of the
genes in the Runx- and Pik3-cluster across diﬀerent scales
(Additional ﬁle 4). The results of this analysis are pre-
sented in Figure 2C, and show that both clusters are highly
enriched for the general pathways in cancer category. It
furthermore shows that the enrichment becomes more
pronounced when the scale is increased and the mini-
mum p-value is attained at diﬀerent scales for each cluster.
The highest enrichments occur at the small-scale for the
Runx-cluster (Figure 3A) and the large-scale for the Pik3-
cluster (Figure 3B). Similar observations can be made for
leukemia pathways (dashed lines in Figure 2C). Notably,
overlaps between the insertional mutations in mouse
lymphomas and copy number variation in human acute
myeloid leukemia and SNPs in human chronic myeloid
leukemia have been observed previously [11].
In addition to the Runx- and Pik3-cluster, the Gﬁ-cluster
is apparent at the medium-scale. This cluster includes
important cancer related genes such asGﬁ1,Myb [11] and
Nocht1 [10] (Figure 3C). The Gﬁ-cluster is enriched for
pathways in cancer category (p-value = 0.06) and chronic
myeloid leukemia pathway (p-value = 0.04). Interestingly,
this cluster is exclusively apparent at the medium-scale.
Next, for the Runx- and Pik3-cluster, we select the scales
for which the minimum p-value is attained and deter-
mined enrichments in other KEGG pathways. Table 1
summarizes the results by showing the p-value and rank
of the most enriched pathways. Although most promi-
nent cancer related pathways are enriched for both
clusters, the top-ranked pathways are notably diﬀerent.
Taken together, these results clearly illustrate the bene-
ﬁt of multi-scale analysis when determining ReMIC gene
clusters.
ReMIC gene clusters exhibit a pattern of mutual exclusive
mutation
A hallmark of cancer is that mutations of many diﬀerent
genes can lead to alteration of the same pathway. More-
over, once the proliferative advantaged is conferred, addi-
tional mutations in the deregulated pathway are less likely
to occur. Mutually exclusive mutations, therefore, provide
evidence that the altered genes are functionally linked in a
common biological pathway [35]. To test this conjecture,
we employ the test for mutual exclusion presented in the
MEMo algorithm [35]. To this end, the MEMo permuta-
tion procedure is applied to identify whether the clustered
ReMIC genes exhibit a pattern of mutual exclusion that
extends beyond one expected by chance. The results are
shown at Figure 2D for the Runx- and Pik3-cluster across
the scales.
From these results it follows that both clusters exhibit
a signiﬁcant pattern of mutual exclusion (p < 0.05). It is
particularly striking that the strongest signiﬁcance levels
for both clusters arise at diﬀerent scales. For ReMIC genes
within the Runx-cluster, mutual exclusion is strongest at
the small diﬀusion scale (Additional ﬁle 2: Figure S4),
whereas for the Pik3-cluster this occurs at the large-
scale (Additional ﬁle 2: Figure S5). These scales coin-
cide with the scales of maximum functional enrichment
(Figure 2D). These results illustrate the importance of a
multi-scale deﬁnition of the pathway context in which
mutations occur.
ReMIC clusters include many non-CIS genes
For all ReMIC clusters with β > 0 it is apparent that
they contain genes that harbored no or only fewmutations
(indicated by white or pink nodes in Figure 2B). There-
fore, these genes would not have been discovered in a
traditional CIS analysis.
Many of the white ReMIC genes are also known and
prominent cancer genes. Examples include Ctnnb1, Jun,
Bcr and Src, which are detected across all the scales. Other
cancer genes are exclusively detected at larger scales, such
as Smad4 and Ntrk1 in the Pik3-cluster. These genes
harbor no mutations in the RIM dataset and are thus
undetectable unless the interaction context is taken into
account.
Also, many pink ReMIC genes represent well-
characterized cancer genes. A prominent example is the
Rbl1 gene in the Runx-cluster. Rbl1 is a tumor-suppressor
gene found to be dysfunctional in many human tumors
including leukemia [11]. Other examples include Raf1
and Ptk2 in the Pik3-cluster [38]. In our data, these genes
are hit in only few tumors, and hence, mutation scores are
insuﬃcient to reach signiﬁcance thresholds.
The question arises whether pink ReMIC genes are
selected simply because they are part of the network
neighborhood of important cancer genes (i.e. the CIS
genes) or, more interestingly, that they are selected due to
the combination of local graph topology and distribution
of mutations across this topology.
To examine this hypothesis, we compare the pink
ReMIC genes from the Runx- and Pik3-cluster with sets
of genes that are not signiﬁcant in our analysis but that
are connected to one of the high-scoring genes in the
same cluster. For both groups of genes, that both harbor
few mutations, enrichments in the two leukemia path-
ways and pathways in cancer are determined. The results
are summarized in Table 2. From these results it follows
that pink ReMIC genes from both clusters rank higher
in the enrichment test for two out of three tested rele-
vant pathways. This is especially apparent for the larger









Figure 3 Prominent ReMIC gene clusters. ReMIC genes in the relevant diﬀusion scale of A) Runx-cluster (consisting of 100 ReMIC genes at the
small-scale), B) Pik3-cluster (consisting of 436 ReMIC genes at the large-scale) and C) Gﬁ-cluster (consisting of 75 ReMIC genes at the medium-scale).
The clusters are visualized using Organic Cytoscape layout [32]. The color of the nodes reﬂects the mutation score before diﬀusion.
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Table 1 Pathway enrichments
KEGG pathways Pik3-cluster Runx-cluster
Rank p -value Rank p -value
Cell cycle 60 0.11 1 1.7E-10
Prostate cancer 4 1.4E-07 2 1.3E-08
Chronic myeloid leukemia 2 4.1E-10 3 3.6E-08
Pathways in cancer 8 3.4E-07 4 9.2E-08
HTLV-I infection 28 0.001 5 5.2E-07
Small cell lung cancer 20 4.6E-05 6 8.9E-07
Colorectal cancer 14 2.1E-06 7 8.3E-06
Glioma 3 3.1E-08 8 5.2E-05
p53 signaling pathway 73 0.27 9 5.3E-05
Transcriptional misregulation
in cancer
77 0.36 10 5.3E-05
T cell receptor signaling path-
way
1 1.1E-11 35 0.47
B cell receptor signaling path-
way
5 1.5E-07 34 0.44
Non-small cell lung cancer 6 1.6E-07 13 0.0002
Fc epsilon RI signaling path-
way
7 3.2E-07 65 0.95
ErbB signaling pathway 9 7.9E-07 21 0.05
Pancreatic cancer 10 8.7E-07 14 0.0003
The top ranked pathways of KEGG enrichment analysis for the Runx- and
Pik3-cluster determined at the small- and large-scale, respectively (Figure 3A, B).
Pik3-cluster, for which substantially lower p-values are
obtained for enrichment in the two leukemia pathways.
We therefore conclude that the local network topology
plays an important role in determining whether genes are
involved in deregulating a pathway.
ReMIC genes co-localize in leukemia pathways
The overlaps between retroviral mutations in mouse lym-
phomas and human myeloid leukemia have been pre-
viously observed [11]. Therefore, most of the selected
CIS genes are implicated in leukemia pathways. To iden-
tify whether the white and pink ReMIC genes are also
part of these pathways we superimpose non-CIS ReMIC
genes that are detected in the Runx- and Pik3-cluster at
the scales for which the strongest KEGG enrichments
are observed and the acute myeloid leukemia KEGG
pathway. ReMIC genes are labeled according to their
appearance in either the Runx- (red) or Pik3-cluster
(blue) cluster (with circle size indicating the number of
ReMIC genes within each KEGG meta-node). The result
is illustrated for the acute myeloid leukemia pathway in
Figure 4 (similar observations can be made for the chronic
myeloid leukemia pathway, shown in the Additional ﬁle 2:
Figure S1).
This reveals that a clear co-localization of the ReMIC
genes in a conﬁned part of the pathway is found. It is
particularly striking that non-CIS ReMIC genes from the
Pik3-cluster all co-localize in the top left of this KEGG
pathway (blue circles in Figure 4). These genes play impor-
tant roles in the ErbB and Mtor signaling pathways,
among others. The non-CIS ReMIC genes in the Runx-
cluster, on the other hand, co-localize in the bottom right.
Similar observations are made in case CIS genes (red
ReMIC genes) are included (shown in the Additional ﬁle 2:
Figure S2 and S3).
Consequently, although this KEGG pathway is enriched
for ReMIC genes, mutations appear to be clustered in
clear mutation hot-spots of the pathway. Moreover, the
ReMIC gene clusters comprise many other genes that are
part of other pathways or not present in any of the path-
ways. This demonstrates the importance of a multi-scale
approach that is based on protein-protein interactions
as opposed to restricting the search for recurrent muta-
tions to single genes (CIS analysis) or enrichment of whole
discretely deﬁned pathways.
Conclusions
Recently, several methods in computational cancer biol-
ogy have been developed to identify signiﬁcantly mutated
pathways using biological networks such as a PPI graph
[21,24-27]. The main strategy of these approaches is to
search for high-scoring subnetworks in terms of a speciﬁc
scoring function. Due to the fact that such problems are
NP-hard, greedy and heuristic approaches are employed
[25-27]. In this study, we propose a graph diﬀusion frame-
work to overcome this diﬃculty.
Table 2 Pink ReMIC genes
KEGG pathways Pink nodes in Pik3-cluster Pink nodes in Runx-cluster
Signiﬁcant Non-signiﬁcant Signiﬁcant Non-signiﬁcant
p -value Rank p -value Rank p -value Rank p -value Rank
AM leukemia 0.002(17/294) 26 0.54(10/933) 61 0.01(6/81) 16 0.001(11/265) 3
CM leukemia 2.5E-07(31/294) 2 0.9(9/933) 101 4.5E-06(12/81) 3 0.001(10/265) 9
Pathways in cancer 8.7E-06(67/294) 11 0.54(45/933) 62 1.3E-05(23/81) 4 2.1E-05(34/265) 1
p-values of pathway enrichment for ReMIC genes and non-selected pink nodes which are connected to the red nodes in the
Runx- and Pik3-cluster. Numbers between parentheses show the number of implicated genes in that particular pathway / total
number of genes in the set.
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Figure 4 Superimposed on the KEGG pathways. The white and pink ReMIC genes are co-localized in a conﬁned part of the acutemyeloid
leukemia pathway. Non-CIS ReMIC genes in the Pik3- and Runx-cluster all co-localize in the top left (blue) and in bottom right (red), respectively.
The multi-scale graph diﬀusion is applied to detect
recurrent gene mutation in the context of the functional
protein-protein interaction network. Using graph diﬀu-
sion, it is possible to capture the local topology of the
interaction network and diﬀuse gene mutation scores
across the interaction graph. The diﬀusion strength acts
as a scale parameter, determining the size of the net-
work neighborhood across which recurrence is detected.
Recurrently mutated genes in interaction context (ReMIC
genes) are identiﬁed by permutation analysis per gene
and scale. This reduces the computational complexity
of examining the virtually limitless number of possible
subnetworks within the complete PPI network.
We apply this method to discover recurrent gene muta-
tions in a large collection of viral mutation data. We
demonstrate that signiﬁcant genes (called ReMIC genes)
are organized in connected components even though the
signiﬁcance estimates are performed on a per gene bases.
These clusters of ReMIC genes are apparent across mul-
tiple diﬀusion scales. In addition to some small clusters,
two major gene clusters are apparent: the Runx- and Pik3-
cluster. We demonstrate that these clusters are strongly
enriched for cancer related pathways. Moreover, genes
within these clusters are signiﬁcantly mutually exclusive
at particular diﬀusion scales, supporting their functional
relation in tumorigenesis. Many ReMIC genes harbor no
or infrequent mutations such as Ctnnb1, Bcr, Src and are,
therefore, not detectable in an ordinary CIS analysis. Lit-
erature provides substantial evidence for their roles in
cancer, particularly in leukemia, illustrating the eﬃcacy of
identifying cancer genes in the context of their functional
interaction network.
Graph diﬀusion has been explored previously to identify
subnetworks harboring frequent mutations in a method
called HotNet [27]. One of the most important diﬀerences
with our method is the way in which the signiﬁcance esti-
mates are calculated. In HotNet, an approximate solution
for the connected maximum coverage problem is adopted
to ﬁnd signiﬁcant mutated subnetworks. This solution is
heuristic and computationally expensive since a myriad
of subnetworks of diﬀerent sizes need to be evaluated.
Importantly, in order for this to become computationally
tractable, white nodes need to be removed and are thereby
excluded from appearing in the resulting subnetworks. In
our method, on the other hand, the whole PPI network
is considered.
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HotNet furthermore requires the user to predeﬁne the
size of the subnetworks that it will ﬁnd. Our approach,
on the other hand, mitigates the need of making prior
assumptions on the size of the ReMIC gene clusters. As a
case in point, we analyze our insertional mutagenesis data
with the HotNet algorithm and demonstrate that, at a par-
ticular diﬀusion scale, our method outperforms HotNet
to detect distinct subnetworks that are related to known
cancer pathways (see Additional ﬁle 2: Supplemental text).
Most importantly, however, we show that for diﬀer-
ent scale levels diﬀerent functional enrichments, mutual
exclusion patterns and ReMIC genes are observed. More-
over, for certain scale levels, clusters of ReMIC genes
exhibit a clear co-localization in speciﬁc hot-spots of the
KEGG representation of the leukemia pathway. Taken
together, this demonstrates the importance of analyzing
gene mutation in the context of their interaction network
in a multi-scale fashion.
Additional ﬁles
Additional ﬁle 1: Source code. A Zip ﬁle containing the source code of
the presented algorithm for Matlab and R and related ﬁles. These ﬁles are
also available on http://bioinformatics.tudelft.nl/users/sepideh-babaei.
Note that the results of this study are calculated by Matlab.
Additional ﬁle 2: Supplementary text. A PDF ﬁle containing the
supplemental ﬁgures and text. It includes a ﬁgure of the ReMIC genes
superimposed on the leukemia KEGG pathways, results of the analysis of
the insertional mutagenesis data with the HotNet algorithm, dendrograms
extracted by the graph clustering technique as well as ﬁgures of the
mutation proﬁles of the ReMIC genes.
Additional ﬁle 3: Lists of ReMIC genes across the scales.MS Excel XLS
tables contain ReMIC genes which are selected across the diﬀusion scales.
Additional ﬁle 4: KEGG pathway enrichments table.MS Excel XLS
tables containing enriched KEGG pathways for both Runx- and Pik3-cluster
across the diﬀusion scales.
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